PUBLICATIONS · 10717522
Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. the Indiana University experience.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Eur J Cancer
- Publication date
- 2000 Mar
- First author
- Behnia M
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Eur J Cancer. 2000 Mar;36(4):440-2. doi: 10.1016/s0959-8049(00)00035-6.
- note
- Source null
- related pmid
- 10717517
- relationship
- Comment in
Authors and identifiers
- name
- Behnia M
- type
- Author
- name
- Foster R
- type
- Author
- name
- Einhorn LH
- type
- Author
- name
- Donohue J
- type
- Author
- name
- Nichols CR
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Behnia M
- type
- Author
- name
- Foster R
- type
- Author
- name
- Einhorn LH
- type
- Author
- name
- Donohue J
- type
- Author
- name
- Nichols CR
- type
- Author
- bibliography ids
- nci-bib-c6a5e40904cc5fddd47d0593
- book metadata
- content sha256
- 5566d44b498587e14de770dfd36c6e0c9096a02e57a75cff5fd56f2317ca45a5
- document type
- citation
- dois
- 10.1016/s0959-8049(99)00316-0
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:10717522
- immutable id
- pubmed:10717522@5566d44b498587e14de770dfd36c6e0c9096a02e57a75cff5fd56f2317ca45a5
- journal
- abbreviation
- Eur J Cancer
- issn electronic
- Source null
- issn print
- 0959-8049
- issue
- 4
- name
- European journal of cancer (Oxford, England : 1990)
- nlm unique id
- 9005373
- pages
- 472-5
- volume
- 36
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Eur J Cancer. 2000 Mar;36(4):440-2. doi: 10.1016/s0959-8049(00)00035-6.
- note
- Source null
- related pmid
- 10717517
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 10717522
- provenance
- batch id
- 40703d4bdd5a70d2c67a
- provider
- NCBI PubMed ESummary
- record sha256
- e03fb0cf19b68e17b4e2ed76dcbf4eb83b9b437706a7ec7dc8b31b420af5660d
- response sha256
- a3c61c2ff7d134e39b75494c75710402933a0e6adc127aa6cbdffc11682a963b
- retrieved at
- 2026-09-09T23:45:35.800055+00:00
- publication date
- display
- 2000 Mar
- precision
- month
- year
- 2000
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. the Indiana University experience.
Preserved source evidence · Not medical advice
Triangle